Crossmark

Melatonin: a ferroptosis inhibitor with potential therapeutic efficacy for the post-COVID-19 trajectory of accelerated brain aging and neurodegeneration

Crossref DOI link: https://doi.org/10.1186/s13024-024-00728-6

Published Online: 2024-04-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yehia, Asmaa

Abulseoud, Osama A. https://orcid.org/0000-0002-0652-0862
License Information

Text and Data Mining valid from 2024-04-19

Version of Record valid from 2024-04-19
More Information

Article History

Received: 7 February 2024

Accepted: 15 April 2024

First Online: 19 April 2024

Declarations

:

: This manuscript does not contain data from any individual person so the consent for publication is not applicable.

: Not applicable. Ethics approval and consent are not indicated due to the review nature of this paper.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below